Literature DB >> 32241880

Drugs and the renin-angiotensin system in covid-19.

Jeffrey K Aronson1, Robin E Ferner2.   

Abstract

Entities:  

Year:  2020        PMID： 32241880     DOI： 10.1136/bmj.m1313

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  37 in total

Review 1.  Acute lung injury - from pathophysiology to treatment.

Authors:  D Mokrá
Journal:  Physiol Res       Date:  2020-12-31       Impact factor: 1.881

2.  Oral Lisinopril Raises Tissue Levels of ACE2, the SARS-CoV-2 Receptor, in Healthy Male and Female Mice.

Authors:  Steven D Brooks; Rachel L Smith; Aline S Moreira; Hans C Ackerman
Journal:  Front Pharmacol       Date:  2022-03-10       Impact factor: 5.810

3.  CORDITE: The Curated CORona Drug InTERactions Database for SARS-CoV-2.

Authors:  Roman Martin; Hannah F Löchel; Marius Welzel; Georges Hattab; Anne-Christin Hauschild; Dominik Heider
Journal:  iScience       Date:  2020-06-20

4.  Predictors of severe or lethal COVID-19, including Angiotensin Converting Enzyme inhibitors and Angiotensin II Receptor Blockers, in a sample of infected Italian citizens.

Authors:  Francesca Bravi; Maria Elena Flacco; Tiziano Carradori; Carlo Alberto Volta; Giuseppe Cosenza; Aldo De Togni; Cecilia Acuti Martellucci; Giustino Parruti; Lorenzo Mantovani; Lamberto Manzoli
Journal:  PLoS One       Date:  2020-06-24       Impact factor: 3.240

5.  Covid-19 and cardiovascular risk: Susceptibility to infection to SARS-CoV-2, severity and prognosis of Covid-19 and blockade of the renin-angiotensin-aldosterone system. An evidence-based viewpoint.

Authors:  Francesco P Cappuccio; Alfonso Siani
Journal:  Nutr Metab Cardiovasc Dis       Date:  2020-05-29       Impact factor: 4.222

6.  Pharmacological characteristics of patients infected with SARS-Cov-2 admitted to Intensive Care Unit in South of France.

Authors:  François Montastruc; Charles Romano; Jean-Louis Montastruc; Stein Silva; Thierry Seguin; Vincent Minville; Bernard Georges; Béatrice Riu-Poulenc; Olivier Fourcade
Journal:  Therapie       Date:  2020-05-15       Impact factor: 2.070

Review 7.  [COVID-19 and its relationship with hypertension and cardiovascular disease].

Authors:  M Salazar; J Barochiner; W Espeche; I Ennis
Journal:  Hipertens Riesgo Vasc       Date:  2020-06-18

8.  Association between renin-angiotensin system inhibitors and COVID-19 complications.

Authors:  Sophie Liabeuf; Julien Moragny; Youssef Bennis; Benjamin Batteux; Etienne Brochot; Jean Luc Schmit; Jean-Philippe Lanoix; Claire Andrejak; Olivier Ganry; Michel Slama; Julien Maizel; Yazine Mahjoub; Kamel Masmoudi; Valérie Gras-Champel
Journal:  Eur Heart J Cardiovasc Pharmacother       Date:  2020-06-12

Review 9.  The mechanistic overview of SARS-CoV-2 using angiotensin-converting enzyme 2 to enter the cell for replication: possible treatment options related to the renin-angiotensin system.

Authors:  Annette Offringa; Roy Montijn; Sandeep Singh; Martin Paul; Yigal M Pinto; Sara-Joan Pinto-Sietsma
Journal:  Eur Heart J Cardiovasc Pharmacother       Date:  2020-09-01

Review 10.  COVID-19: A Multidisciplinary Review.

Authors:  Nour Chams; Sana Chams; Reina Badran; Ali Shams; Abdallah Araji; Mohamad Raad; Sanjay Mukhopadhyay; Edana Stroberg; Eric J Duval; Lisa M Barton; Inaya Hajj Hussein
Journal:  Front Public Health       Date:  2020-07-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.